Virta Health

𝗙𝘂𝗹𝗹 𝗲𝗽𝗶𝘀𝗼𝗱𝗲 𝗶𝘀 𝗡𝗢𝗪 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲! “𝘐 𝘵𝘩𝘪𝘯𝘬 𝘴𝘰𝘮𝘦𝘸𝘩𝘦𝘳𝘦 𝘢𝘭𝘰𝘯𝘨 𝘵𝘩𝘦 𝘭𝘪𝘯𝘦𝘴, 𝘸𝘦 𝘭𝘰𝘴𝘵 𝘵𝘩𝘦 𝘯𝘶𝘵𝘳𝘪𝘵𝘪𝘰𝘯𝘢𝘭 𝘤𝘰𝘮𝘱𝘰𝘯𝘦𝘯𝘵 𝘰𝘧 𝘤𝘰𝘯𝘵𝘳𝘰𝘭𝘭𝘪𝘯𝘨 𝘮𝘦𝘵𝘢𝘣𝘰𝘭𝘪𝘤 𝘩𝘦𝘢𝘭𝘵𝘩, 𝘢𝘯𝘥 𝘪𝘵 𝘣𝘦𝘤𝘢𝘮𝘦 𝘦𝘢𝘴𝘪𝘦𝘳 𝘵𝘰 𝘸𝘳𝘪𝘵𝘦 𝘢 𝘱𝘳𝘦𝘴𝘤𝘳𝘪𝘱𝘵𝘪𝘰𝘯.” - Greeshma Shetty, MD Thank you to 𝘛𝘩𝘦 𝘋𝘳. 𝘏𝘺𝘮𝘢𝘯 𝘚𝘩𝘰𝘸 for having us on to discuss the power of nutrition in reversing chronic disease with Mark Hyman, MD. In this episode, Virta Co-founder & CEO Sami Inkinen and Director of Quality and Safety Dr. Greeshma Shetty share our groundbreaking research that’s forever changed the way we view treatment of metabolic diseases like obesity and diabetes—without relying on drugs like Ozempic. Listen to the full episode here:  Apple - https://apple.co/4aZjwpi Spotify - https://spoti.fi/3EKdOvu #VirtaHealth #MetabolicHealth #ChronicDisease #SustainableWeightLoss #DiabetesReversal 

🚨 The GLP-1 cost crisis is real—and growing. But what if you could cut usage in half while still driving meaningful weight loss and saving millions? Early results are in: Virta is doing exactly that. 👇 💊 >50% reduction in ongoing GLP-1 use for weight loss ⚖️ ~5% average weight loss in just 90 days—with or without GLP-1s, with previously reported one year weight loss outcomes of 13% without GLP-1s 💰 Major cost savings for payers, without compromising outcomes Demand for smart and sustainable weight loss care has fueled Virta’s revenue growth to 80% in Q1'25, up from 60% in 2024. As employers and health plans face soaring GLP-1 costs projected to top $100B annually, Virta has shown that the future of weight loss care doesn’t rely on expensive, lifetime prescriptions. This isn’t just cost control—it’s the responsible approach to addressing obesity and covering GLP-1s while maximizing health outcomes. Learn more about today's announcement: https://lnkd.in/gzA_Gzk9 #VirtaHealth #GLP1 #WeightLoss #ResponsiblePrescribing #HealthcareInnovation #ValueBasedCare #NutritionFirst #ObesityCare

Join us at the Conference Board's Employee Health Care Conference in NYC for a real-world debate on what’s working, what’s not, and where GLP-1 strategies are headed next. April 8 | 11:00 – 11:40 AM Featuring: 🔹 Niki Bourque, Regions 🔹 Nicole Cody, International Paper 🔹 Jonathan Pearlstein, Virta Health Let’s talk about what’s next in obesity & diabetes care. See you there! #GLP1 #EmployeeBenefits #ObesityCare #HealthCareStrategy #ConferenceBoard

“Most people regain the weight.” That’s what the research says about stopping GLP-1 medications like Mounjaro or Ozempic. But this member didn’t. In fact—they lost 20 more pounds after stopping the drug and joining Virta for a structured, sustainable approach to nutrition. Expert coaching, daily biomarker tracking, lifestyle support, and real accountability makes for a powerfully effective off-ramp. Brad's not alone. For the millions seeking a long-term alternative to costly medications, Virta offers more than hope—we offer a proven path forward. https://lnkd.in/gv4iKMVz #VirtaHealth #GLP1 #MetabolicHealth #WeightLoss #Nutrition

🚨 Last Call: Senior Benefits Consultants—Only a Few Seats Left! 🚨 Join us for the Metabolic Reversal Roadshow at Mercedes-Benz Stadium on March 26th before spots run out! ✅ GLP-1s, diabetes care & Rx cost-saving strategies 🏟️ Private stadium tour 👕 Custom Falcons jersey 🍽️ Lunch included March 26, 2024 | Falcons Locker Room, Mercedes-Benz Stadium Final spots available—register now! Claim your seat → https://lnkd.in/gK4XqqcG #MetabolicReversalRoadshow #BenefitsConsultants #EmployeeBenefits #GLP1

Nutrition isn’t as easy as "eat less, move more." Yet, the core of healthy eating can be remarkably simple: prioritizing proteins and healthy fats, mitigating sugar and processed foods, and above all, consistency. 💪 Our founder + CEO Sami Inkinen sits down with Christina Farr, Luba Greenwood, J.D., and Ash Zenooz, MD to talk about the power of food in reversing chronic diseases, how flexibility and intense personalization promotes sustainability, and the impact of popular weight loss drugs like GLP1s. Tune in to the latest episode of Second Opinion below. https://lnkd.in/guRdfwqZ

Nutrition isn’t as easy as "eat less, move more." Yet, the core of healthy eating can be remarkably simple: prioritizing proteins and healthy fats, mitigating sugar and processed foods, and above all, consistency. 💪 Our founder + CEO Sami Inkinen sits down with Christina Farr, Luba Greenwood, J.D., and Ash Zenooz, MD to talk about the power of food in reversing chronic diseases, how flexibility and intense personalization promotes sustainability, and the impact of popular weight loss drugs like GLP1s. Tune in to the latest episode of Second Opinion below. https://lnkd.in/guRdfwqZ

Senior Director of Sales, Brett R., shared what about Virta drew him to come be a part of our team. We are so thankful for Brett and everyone at Virta for their continuous contribution towards changing lives. Join our Talent Community to stay up to date at https://lnkd.in/gkFPgsDJ to stay connected! #LifeAtVirta

💡 Senior Benefits Consultants: Stay Ahead in Metabolic Health & Rx Strategy Join industry leaders like UPS, Newell Brands, Smurfit Westrock and more at the Metabolic Reversal Roadshow for insights on: 🔹 GLP-1s & responsible prescribing for 2025 🔹 Virta’s expanding product portfolio 🔹 Sustainable weight loss & diabetes care 🏟️ Exclusive stadium tour | 👕 Custom Falcons jersey | 🍽️ Lunch included March 26, 2024 | Falcons Locker Room, Mercedes-Benz Stadium Seats are limited—don’t wait! Register now → https://lnkd.in/gK4XqqcG #MetabolicReversalRoadshow #BenefitsConsultants #EmployeeBenefits #GLP1

We’re excited to share data on the safety of Virta’s approach for individuals on Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors. Key findings include: ✅ Virta’s approach does not raise the risk of Diabetic Ketoacidosis (DKA) ✅ Virta’s monitoring appears to offer a reasonably safe way for individuals to combine very low carb nutrition with SGLT2 inhibitors. This is a significant step forward in ensuring the safety and effectiveness of our treatment for a broader range of patients. Want to dive deeper into the findings? 📖 Click the link to read the full paper! https://lnkd.in/gj74SrQ5